Pliant Therapeutics
2016
FOUNDED
PRIVATE
STATUS
61-70
EMPLOYEES
Series C
LATEST DEAL TYPE
$48.2M
LATEST DEAL AMOUNT
9
INVESTORS
Description
Developer of new therapies designed to treat fibrotic disorders. The company's therapies prevent or even reverse fibrosis to address the needs of many patients, enabling patients to begin treatment more quickly and result in a higher likelihood of successful treatment.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 260 Littlefield Avenue
- San Francisco, CA 94080
- United States
+1 (650) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Pliant Therapeutics’s full profile, request a free trial.
Pliant Therapeutics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series C) | 08-Jan-2020 | $48.2M | 00000 | 00000 | Completed | Generating Revenue |
| 3. Corporate | 23-Oct-2019 | 0000 | 00000 | Completed | Generating Revenue | |
| 2. Early Stage VC (Series B) | 16-Jul-2018 | $62M | $107M | 00000 | Completed | Generating Revenue |
| 1. Early Stage VC (Series A) | 17-Feb-2016 | $45M | $45M | 0000 | Completed | Generating Revenue |
Pliant Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series B | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series A | 56,000,000 | $0.000100 | $0.08 | $1 | $1 | 1x | $1 | 34.36% |
Pliant Therapeutics Competitors (15)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Recursion Pharmaceuticals | Venture Capital-Backed | Salt Lake City, UT | 000 | 00000 | 000000000 | 00000 |
| 00000 000000000000 | Formerly VC-backed | Waltham, MA | 00 | 000.00 | 000000 - 000 | 000.00 |
| 00000 00000000 | Venture Capital-Backed | San Francisco, CA | 00 | 000.00 | 00000000000 | 000.00 |
| 000000 00000000000 | Venture Capital-Backed | Irvine, CA | 0 | 000.00 | 000000&0 | 000.00 |
| 000000000 | Venture Capital-Backed | Atlanta, GA | 00 | 000.00 | 00000000000 | 000.00 |
Pliant Therapeutics Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Novartis | Corporation | Minority | 000 0000 | 000000 0 | ||
| Agent Capital | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Cowen Healthcare Investments | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Eventide Asset Management | Asset Manager | Minority | 000 0000 | 000000 0 | ||
| Menlo Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |
Pliant Therapeutics Executive Team (15)
4 Former Executives
You’re viewing 5 of 15 executives. Get the full list »Pliant Therapeutics Board Members (10)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Charles Homcy MD | Third Rock Ventures | Board Member | 000 0000 | |
| Craig Muir | Third Rock Ventures | Board Member | 000 0000 | |
| Gayle Crowell | Self | Board Member | 000 0000 | |
| Hoyoung Huh Ph.D | Self | Chairman | 000 0000 | |
| John Curnutte MD | Self | Board Member | 000 0000 |
1 Former Board Member
You’re viewing 5 of 10 board members. Get the full list »